Danish medtech company Brainreader A/S has successfully completed a financing round of USD 7.3 million (EUR 6.6 million) to accelerate the global rollout of its AI-driven diagnostic platform Neuroreader. The round was led by new strategic investor Dahlgren Capital, with continued support from existing shareholder Investo Capital.
The capital injection marks a major milestone for Brainreader as it scales commercial operations, particularly in the U.S. healthcare market, and continues the development of new features and clinical applications.
“This investment allows us to expand faster and reach more clinics worldwide,” says Mads Fiig, CEO of Brainreader. “We’re proud to have the backing of Dahlgren Capital and Investo Capital, whose combined experience in AI and growth-stage companies will be instrumental in our next phase.”
Neuroreader is a CE-marked and FDA-cleared software platform that delivers automated volumetric analysis of brain MRI scans. Used by radiologists and neurologists in clinical practice, it aids in the diagnosis and monitoring of neurological conditions such as Alzheimer’s disease, traumatic brain injury, and other neurodegenerative disorders.
The technology integrates directly into standard workflows, enabling healthcare professionals to detect subtle changes in brain structure faster and with greater precision.
“Brainreader is building a category-defining solution in AI-enabled brain diagnostics,” says Peter Dahlgren, CEO of Dahlgren Capital. “We are excited to support the team as they scale globally and bring cutting-edge neuroimaging tools to more clinicians and patients.”
Brainreader is well-positioned to capitalize on favorable market dynamics. In the U.S., the adoption of CPT codes for brain volumetry is creating new reimbursement pathways. In the EU, compliance with Medical Device Regulation (MDR) enables broader clinical use of AI-powered imaging tools across member states.
“We see strong tailwinds for AI in neuroimaging,” adds Thor Birkmand, Chairman of Brainreader and partner at Investo Capital. “With this funding and the addition of Dahlgren Capital as an active owner, Brainreader is well-equipped to lead this transformation.”
For media inquiries, please contact:
Sabina Ribbing, press contact Dahlgren Capital
+46 764191239, sabina@pressfwd.se
Mads Fiig, CEO at Brainreader
mfiig@brainreader.net
About Brainreader:
Brainreader is a leading provider of neuroimaging solutions dedicated to improving diagnostic capabilities in clinical neuroscience through advanced software. The company's flagship product, Neuroreader, has received both CE mark and FDA clearance, demonstrating its compliance with international and US regulatory standards. Neuroreader's unique feature lies in its ability to post-process DICOM images from MRI scans, providing efficient and accurate segmentation, used to aid in identifying neurodegenerative diseases. Additionally, Neuroreader offers easy workflow integration, greatly enhancing the diagnostic process for radiologists, reducing their workload, and improving patient care.
About Dahlgren Capital:
About Dahlgren Capital: Dahlgren Capital is an investment firm focused on fintech, cybersecurity, AI, and automation, built on a foundation of active ownership and long-term value creation. With a strong growth trajectory and a team combining deep financial and operational expertise, Dahlgren Capital is well positioned to continue delivering results and opportunities for both investors and portfolio companies. For more information, visit dahlgrencap.com
About Investo Capital:
Investo Capital is a venture capital firm focused on seed and early-stage technology-based companies within healthcare, environment sustainability and enterprise technology. With an extensive track record in Nordic venture, and having managed companies ourselves as executives, the team in Investo Capital engages with a partnership-based approach as active owner in the development of our portfolio companies. As investor, Investo Capital places great emphasis on the potential for value creation through international growth and the transformative potential stemming from the core technology. For more information, visit investo.dk